Director, See Remarks · Caris Life Sciences, Inc. · Common Stock
Side
SELL
Value
$12.13M
Shares
400.0K
Price
$30.33
Executed
Sep 17, 2026
Disclosed
Sep 17, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Sep 17 executedSep 17, 2026 disclosed
CAI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Brille Brian J filed this Form 4 reporting a open-market sale of CAI on Sep 17, 2026. It became public on Sep 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, See Remarks
Brille Brian Jcik:0002071959
Issuer
Caris Life Sciences, Inc.cik:0002019410
Revision history · 0
No field has changed since this record was first ingested.
